Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Sinks 36 Points. More details...
Company Seeks $715 Million Valuation -- As we reported...
Second Quarter Revenue Lower Than First Quarter WuXi...
Stock Opens 30% Higher WuXi PharmaTech...
Second Quarter Reports Are Solid Last week saw the very...
Will the Swiss Biotech Move the Funds to China?...
WuXi Pharmatech released its second quarter...
WEX Pharmaceuticals, a Vancouver-based company with...
WuXi PharmaTech, the very successful Shanghai-based...
Anesiva formed a joint venture with Wanbang Biopharma, a...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
